Thomas Burris, chair of pharmacology and physiology at Saint Louis University (US) has developed a new drug "SR9243" which can stop cancer cell growth by targeting a trait of cancer cell metabolism. Published in the journal 'Cancer Cell', the study was conducted on animal models and human tumor cells in the lab. The drug remains non-toxic to healthy cells.